StocksI › INTC

Intel Corporation (INTC) — Earnings Call X-Ray

Our AI read all 39 of INTC's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2025 · sign up to see
Previous Call Grade
F
Q1 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
39
2016–2025
Avg Candor
6.9/9
evasion 2.8/9
Guidance LoweredHigh CandorCritic AmmunitionUnderused Fixed CostsPricing Under PressureMargins ContractingCutting HeadcountQuestion Left Hanging

Call-by-call analysis

🔒 Q2 2025 earnings call 2025-07-24 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2025 call grade is ready
The full 37-point AI read of INTC's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

F Q1 2025 earnings call 2025-04-24 move ±19.6%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 10 analysts · 20 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 7/9
Evasion 4/9
Confidence 5/9
Uncertainty 7/9
Promotion 3/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q4 2024 earnings call 2025-01-30 move ±11.3%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 9 analysts · 17 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up aheadCFO dominatesDirection beats results
Candor 8/9
Specificity 7/9
Evasion 2/9
Confidence 4/9
Uncertainty 6/9
Promotion 3/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q3 2024 earnings call 2024-10-31 move ±14.2%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: contractingBacklog: growingPricing: under pressureHeadcount: cuttingCapex: decreasing 8 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growthHidden segmentDirection beats results
Candor 7/9
Specificity 7/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 6/9
Stress 5/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q2 2024 earnings call 2024-08-01 move ±31.7%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics, visibly under pressure.

Guidance: loweredDemand: slowingMargins: contractingBacklog: stablePricing: under pressureHeadcount: cuttingCapex: decreasing 6 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growthDirection beats results
Candor 8/9
Specificity 8/9
Evasion 3/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 7/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q1 2024 earnings call 2024-04-25 move ±16.6%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was rich in specifics, promotional in tone.

Guidance: maintainedDemand: mixedMargins: contractingBacklog: growingPricing: raisingCapex: flat 7 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsedHidden segment
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 8/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

D Q4 2023 earnings call 2024-01-25 move ±18.1%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics, promotional in tone.

Guidance: loweredDemand: mixedMargins: contractingBacklog: growingPricing: stableCapex: increasing 6 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 8/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q3 2023 earnings call 2023-10-26 move ±15.3%

Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics, promotional in tone.

Guidance: maintainedDemand: stableMargins: expandingBacklog: growingPricing: raisingCapex: increasing 7 analysts · 12 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 2/9
Promotion 8/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2023 2023-07-27 B+ raisedmixedexpanding 7/9 2/9
Q1 2023 2023-04-27 C maintainedmixedcontracting 7/9 3/9
Q4 2022 2023-01-26 F loweredslowingcontracting 8/9 4/9
Q3 2022 2022-10-27 D loweredslowingcontracting 7/9 3/9
Q2 2022 2022-07-28 F loweredslowingcontracting 7/9 3/9
Q1 2022 2022-04-28 F maintainedmixedcontracting 6/9 3/9
Q4 2021 2022-01-26 C+ maintainedacceleratingcontracting 7/9 3/9
Q3 2021 2021-10-21 D raisedacceleratingcontracting 6/9 3/9
Q2 2021 2021-07-22 D raisedacceleratingcontracting 6/9 3/9
Q1 2021 2021-04-23 D raisedacceleratingcontracting 6/9 3/9
Q4 2020 2021-01-22 F nonemixedcontracting 6/9 6/9
Q3 2020 2020-10-22 C raisedmixedcontracting 6/9 3/9
Q2 2020 2020-07-23 D raisedmixedcontracting 7/9 4/9
Q1 2020 2020-04-23 C withdrawnmixedcontracting 7/9 3/9
Q4 2019 2020-01-23 B+ raisedacceleratingcontracting 7/9 2/9
Q3 2019 2019-10-24 B+ raisedacceleratingcontracting 8/9 2/9
Q2 2019 2019-07-25 B+ raisedmixedcontracting 7/9 2/9
Q1 2019 2019-04-25 D loweredslowingcontracting 8/9 3/9
Q4 2018 2019-01-24 C loweredslowingcontracting 7/9 2/9
Q3 2018 2018-10-25 B+ raisedacceleratingexpanding 8/9 2/9
Q2 2018 2018-07-26 B+ raisedacceleratingexpanding 6/9 2/9
Q1 2018 2018-04-26 B+ raisedacceleratingexpanding 7/9 2/9
Q4 2017 2018-01-25 B+ raisedacceleratingcontracting 7/9 2/9
Q3 2017 2017-10-26 B+ raisedstableexpanding 7/9 3/9
Q2 2017 2017-07-27 B+ raisedacceleratingexpanding 8/9 2/9
Q1 2017 2017-04-27 B+ raisedstableexpanding 7/9 2/9
Q4 2016 2017-01-27 C+ maintainedmixedexpanding 7/9 2/9
Q3 2016 2016-10-19 C loweredmixedcontracting 7/9 4/9
Q2 2016 2016-07-20 C+ maintainedmixedstable 6/9 3/9
Q1 2016 2016-04-19 C loweredmixedcontracting 8/9 2/9
Q4 2015 2016-01-14 B+ raisedmixedstable 7/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of INTC's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

D Q2 2021 earnings call 2021-07-22

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAMC · Altisource Asset ManagemAAON · AAON, Inc.AASZF · Atlantic Sapphire ASAAAT · American Assets Trust, IABCD · Cambium Learning Group'sABCO · The Advisory Board

INTA   All “I” companies    INTL

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.